St. Jude Fortifies AF Business With HIFU Market Development, R&D Initiatives
This article was originally published in The Gray Sheet
Executive Summary
The president of St. Jude Medical's fledgling AF division, Jane Song, is tasked with establishing 10-15 "centers of excellence" in preparation for the firm's high intensity focused ultrasound (HIFU) launch
You may also be interested in...
St. Jude Credits Soaring ICD Sales To Its Product Line, Not Guidant Recall
St. Jude Medical says it will continue marketing its products with the assumption that Guidant's resynchronization defibrillators (CRT-D) will return to the market by the end of the third quarter
St. Jude Credits Soaring ICD Sales To Its Product Line, Not Guidant Recall
St. Jude Medical says it will continue marketing its products with the assumption that Guidant's resynchronization defibrillators (CRT-D) will return to the market by the end of the third quarter
Cryoablation Safer Than RF In Treating Atrial Fib, Trial Sponsor Says
CryoCath expects to learn by April whether FDA will require a follow-up period of longer than six months for a pivotal study of the Arctic Front ablation catheter to treat chronic atrial fibrillation